[18F]FDG-PET/CT in Polymyalgia Rheumatica: An Update and Future Aspects

Olivier Gheysens1, Marie Péan de Ponfilly2, Gaetane Nocturne2

  • 1Department of Nuclear Medicine, Cliniques Universitaires St-Luc and Institute for Experimental and Clinical Research (IREC), Université Catholique de Louvain, Brussels, Belgium.

PubMed
Summary

Polymyalgia rheumatica (PMR) is an inflammatory condition affecting those over 50. [18F]FDG-PET/CT imaging aids in diagnosing PMR, assessing associated giant cell arteritis, and differentiating it from other arthritides.